Source comparison
Quickcomparison
Dose Range Thymosin Alpha-1 1.6–3.2 mg Thymalin 5–10 mg Frequency Twice weekly Once daily Administration Subcutaneous injection Intramuscular injection Cycle Length 8-12 weeks 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Pha
This comparison does not assign a generated winner or score.
- Dose Range
- Thymosin Alpha-1
- 1.6–3.2 mg
- Thymalin
- 5–10 mg
- Frequency
- Twice weekly
- Once daily
- Administration
- Subcutaneous injection
- Intramuscular injection
- Cycle Length
- 8-12 weeks
- 4-6 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Limited human trials
- Efficacy